[{"address1": "401 Professional Drive", "address2": "Suite 260", "city": "Gaithersburg", "state": "MD", "zip": "20879", "country": "United States", "phone": "240 403 4212", "website": "https://www.shuttlepharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter Dale Dritschilo M.B.A., M.D.", "age": 55, "title": "President & COO", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 236000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mira  Jung Ph.D.", "age": 75, "title": "Co-Founder & Chief Scientific Officer for Biology", "yearBorn": 1949, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tyvin A. Rich M.D.", "age": 75, "title": "Chief Clinical Officer & Chief Medical Officer", "yearBorn": 1949, "fiscalYear": 2024, "totalPay": 218000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher Robert Cooper BBA, M.B.A., MBA", "age": 54, "title": "Interim Co-Chief Executive Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Milton  Brown CSC, M.D., Ph.D.", "age": 59, "title": "Co-Founder", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.4001, "open": 0.4378, "dayLow": 0.39, "dayHigh": 0.4378, "regularMarketPreviousClose": 0.4001, "regularMarketOpen": 0.4378, "regularMarketDayLow": 0.39, "regularMarketDayHigh": 0.4378, "payoutRatio": 0.0, "beta": 0.538, "volume": 60344, "regularMarketVolume": 60344, "averageVolume": 132967, "averageVolume10days": 59710, "averageDailyVolume10Day": 59710, "bid": 0.28, "ask": 0.52, "bidSize": 2, "askSize": 2, "marketCap": 2440499, "fiftyTwoWeekLow": 0.331, "fiftyTwoWeekHigh": 4.712, "fiftyDayAverage": 0.5644, "twoHundredDayAverage": 1.444995, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 843189, "profitMargins": 0.0, "floatShares": 3618483, "sharesOutstanding": 6257690, "sharesShort": 38633, "sharesShortPriorMonth": 25655, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0062, "heldPercentInsiders": 0.27056998, "heldPercentInstitutions": 0.0614, "shortRatio": 0.15, "shortPercentOfFloat": 0.0070999996, "impliedSharesOutstanding": 6257690, "bookValue": 0.174, "priceToBook": 2.2413793, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -9144797, "trailingEps": -3.3, "lastSplitFactor": "1:8", "lastSplitDate": 1723507200, "enterpriseToEbitda": -0.11, "52WeekChange": -0.8839286, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 0.39, "recommendationKey": "none", "totalCash": 1920144, "totalCashPerShare": 0.471, "ebitda": -7690707, "totalDebt": 1173472, "quickRatio": 1.252, "currentRatio": 1.441, "debtToEquity": 165.475, "returnOnAssets": -1.1374099, "returnOnEquity": -3.83838, "freeCashflow": -4176872, "operatingCashflow": -7327230, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SHPH", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Shuttle Pharmaceuticals Holding", "exchange": "NCM", "messageBoardId": "finmb_319499082", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Shuttle Pharmaceuticals Holdings, Inc.", "corporateActions": [], "postMarketTime": 1743809178, "regularMarketTime": 1743796800, "marketState": "CLOSED", "regularMarketChangePercent": -2.5243707, "regularMarketPrice": 0.39, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1661952600000, "postMarketChangePercent": 14.8462, "postMarketPrice": 0.4479, "postMarketChange": 0.0579, "regularMarketChange": -0.010100007, "regularMarketDayRange": "0.39 - 0.4378", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 132967, "fiftyTwoWeekLowChange": 0.058999985, "fiftyTwoWeekLowChangePercent": 0.17824769, "fiftyTwoWeekRange": "0.331 - 4.712", "fiftyTwoWeekHighChange": -4.322, "fiftyTwoWeekHighChangePercent": -0.91723263, "fiftyTwoWeekChangePercent": -88.39286, "epsTrailingTwelveMonths": -3.3, "fiftyDayAverageChange": -0.17440003, "fiftyDayAverageChangePercent": -0.30900076, "twoHundredDayAverageChange": -1.0549951, "twoHundredDayAverageChangePercent": -0.7301029, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "Shuttle Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]